Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Endosc. Apr 16, 2013; 5(4): 141-147
Published online Apr 16, 2013. doi: 10.4253/wjge.v5.i4.141
Published online Apr 16, 2013. doi: 10.4253/wjge.v5.i4.141
Tumors and new endoscopic ultrasound-guided therapies
Silvia Carrara, Maria Chiara Petrone, Pier Alberto Testoni, Paolo Giorgio Arcidiacono, Scientific Institute San Raffaele, Vita-Salute San Raffaele University, 20132 Milan, Italy
Author contributions: All the authors gave substantial contributions to conception and design, acquisition of data, and analysis and interpretation of data; drafting the article or revising it critically for important intellectual content; and final approval of the version to be published.
Correspondence to: Silvia Carrara, MD, Scientific Institute San Raffaele, Vita-Salute San Raffaele University, Via Olgettina 60, 20132 Milano, Italy. carrara.silvia@hsr.it
Telephone: +39-22-6435509 Fax: +39-22-6435509
Received: September 13, 2012
Revised: February 17, 2013
Accepted: March 8, 2013
Published online: April 16, 2013
Revised: February 17, 2013
Accepted: March 8, 2013
Published online: April 16, 2013
Core Tip
Core tip: New operative procedures have been developed on the principle of the endoscopic ultrasound (EUS)-guided puncture. A hybrid probe combining radiofrequency with cryotechnology is now available, to be passed through the operative channel of the echoendoscope into the tumor to create an area of ablation. The potential advantage of an ablation device employed under EUS control is the real-time imaging guidance into a deep target like the pancreas which is extremely difficult to reach by a percutaneous approach.